{"id":"W4414886615","doi":"10.1038/s41591-025-03961-8","title":"Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Calgary","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Abiraterone acetate; Hazard ratio; Prednisone; Prostate cancer; Clinical endpoint; Placebo; Confidence interval; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00234443,0.001707601,0.002611279,0.0004244638,0.0004130091,0.001129164,0.0009387214,0.001522245,0.00548733],"category_scores_gemma":[0.001841513,0.0006504296,0.00243232,0.0004716846,0.001118081,0.0009285848,0.0004188931,0.002798102,0.0007872697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006933956,"about_ca_system_score_gemma":0.001526071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001004596,"about_ca_topic_score_gemma":0.002094032,"domain_scores_codex":[0.9991709,0.000525917,0.00003540657,0.0001125214,0.00006098071,0.00009428822],"domain_scores_gemma":[0.9989921,0.0003151664,0.0002347196,0.00008537353,0.00006009471,0.0003124547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9810364,0.004924343,0.0002956134,0.0004019403,0.0005899182,0.00003501864,0.00003783443,0.0003729219,0.001843488,0.0000816758,0.0005086839,0.009872204],"study_design_scores_gemma":[0.9583883,0.03986042,0.000605456,0.00001963826,0.000225094,0.00002777043,0.00001001894,0.0002753515,0.0001680601,0.0001134974,0.0002982608,0.000008091425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9820487,0.006581172,0.0008310873,0.000939267,0.0007349591,0.005472462,0.001193068,0.0001761091,0.002023151],"genre_scores_gemma":[0.9817362,0.004394112,0.001800837,0.001559404,0.0007089393,0.005717559,0.001162121,0.00003231068,0.002888471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00548733,"threshold_uncertainty_score":0.01835692,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02724839226654019,"score_gpt":0.4052032772086769,"score_spread":0.3779548849421367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}